Lantern Pharma(LTRN) - 2024 Q4 - Earnings Call Transcript

Lantern Pharma (LTRN) Q4 2024 Earnings Call March 28, 2025 07:20 AM ET Company Participants Panna Sharma - President, Chief Executive Officer & DirectorDavid Margrave - Chief Financial Officer & Secretary Conference Call Participants None - Analyst Panna Sharma And and we were very excited to establish a scientific advisory board that, is joined by experts such as doctors Mitch Berger at UCSF, Doctor. Lisa DeAngelis at Memorial Sloan Kettering and doctors Stuart Grossman and John Latera at Johns Hopkins, al ...